---
title: "\"King of Pharma\" Delivers Stellar Q1 Report, Goldman Sachs Comments on WuXi AppTec: Full-Year Performance Still Has Upside Potential"
type: "Topics"
locale: "en"
url: "https://longbridge.com/en/topics/40284271.md"
description: ""King of Drugs" Delivers a Stellar Q1 Report"
datetime: "2026-04-29T11:21:36.000Z"
locales:
  - [en](https://longbridge.com/en/topics/40284271.md)
  - [zh-CN](https://longbridge.com/zh-CN/topics/40284271.md)
  - [zh-HK](https://longbridge.com/zh-HK/topics/40284271.md)
author: "[智通财经APP](https://longbridge.com/en/profiles/14718593.md)"
---

# "King of Pharma" Delivers Stellar Q1 Report, Goldman Sachs Comments on WuXi AppTec: Full-Year Performance Still Has Upside Potential

"King of Pharma" Delivers Stellar Q1 Report; Goldman Sachs Comments on WuXi AppTec: Full-Year Performance Still Has Room to Grow  
#Innovative Drugs #WuXi AppTec$WUXI APPTEC(02359.HK) $WuXi AppTec(603259.SH)

### Related Stocks

- [02359.HK](https://longbridge.com/en/quote/02359.HK.md)
- [603259.CN](https://longbridge.com/en/quote/603259.CN.md)